We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

111 hedge funds and large institutions have $225M invested in Arena Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $1.17M | Put options by funds: $931K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

8% less capital invested

Capital invested by funds: $245M → $225M (-$19.6M)

8% less funds holding

Funds holding: 121 → 111 (-10)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

Holders
111
Holders Change
-10
Holders Change %
-8.26%
% of All Funds
2.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
39
Reduced
35
Closed
16
Calls
$1.17M
Puts
$931K
Net Calls
+$240K
Net Calls Change
-$861K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.79M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.08M
3
RCM
RA Capital Management
Massachusetts
+$1.04M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$869K
5
QIM
Quantitative Investment Management
Virginia
+$254K

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$19.9M
2
Millennium Management
Millennium Management
New York
-$3.11M
3
State Street
State Street
Massachusetts
-$1.98M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.95M
5
AC
Ascend Capital
California
-$1.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
$115K -$69.1K -4,309 -43%
UBS Group
52
UBS Group
Switzerland
$109K -$519K -32,404 -85%
Legal & General Group
53
Legal & General Group
United Kingdom
$104K -$128 -8 -0.2%
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$103K – – –
VKH
55
Virtu KCG Holdings
New York
$102K -$69.8K -4,358 -46%
Millennium Management
56
Millennium Management
New York
$96K -$3.11M -194,116 -98%
HK
57
Horizon Kinetics
New York
$89K – – –
LWM
58
Lyons Wealth Management
Florida
$84K -$22.9K -1,426 -25%
Principal Financial Group
59
Principal Financial Group
Iowa
$83K +$2.24K +140 +3%
Creative Planning
60
Creative Planning
Kansas
$80K +$5.61K +350 +9%
Barclays
61
Barclays
United Kingdom
$76K -$251K -15,641 -67%
Canada Pension Plan Investment Board
62
Canada Pension Plan Investment Board
Ontario, Canada
$73K -$121K -7,580 -67%
Commonwealth Equity Services
63
Commonwealth Equity Services
Massachusetts
$64K +$51.8K +3,232 New
Invesco
64
Invesco
Georgia
$63K -$3.41K -213 -6%
HSBC Holdings
65
HSBC Holdings
United Kingdom
$61K +$1.31K +82 +3%
VFS
66
VSR Financial Services
Kansas
$59K – – –
CA
67
Commerzbank Aktiengesellschaft
Germany
$59K +$32 +2 +0.1%
Teacher Retirement System of Texas
68
Teacher Retirement System of Texas
Texas
$58K +$13K +814 +38%
Tudor Investment Corp
69
Tudor Investment Corp
Connecticut
$55K -$139K -8,642 -75%
ASN
70
Advisory Services Network
Georgia
$54K +$44.1K +2,751 New
TC
71
TFS Capital
Pennsylvania
$54K +$44.3K +2,764 New
AB
72
Amalgamated Bank
New York
$50K +$3.62K +226 +10%
Prudential Financial
73
Prudential Financial
New Jersey
$48K +$641 +40 +2%
RJFSA
74
Raymond James Financial Services Advisors
Florida
$48K +$38.7K +2,416 New
AIP
75
Ameritas Investment Partners
Nebraska
$39K – – –
1 2
3
4 5

ARNA Hedge Fund Activity: Q1 2016 in Review

111 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2016, worth a combined $225M — down 8% from $245M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ARNA and 7 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 39 added.

The largest buyer was Wellington Management Group, adding an estimated $2.79M. The largest seller was Camber Capital Management, exiting entirely with an estimated $19.9M sold.

  • 111 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $225M of Arena Pharmaceuticals Inc stock for Q1 2016, down 8% quarter-over-quarter.
  • 7 funds opened new Arena Pharmaceuticals Inc positions in Q1 2016 and 16 closed out, a net change of -9 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2016 was Wellington Management Group, an estimated $2.79M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2016 was Camber Capital Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q1 2016.